Humasis Co Ltd
KOSDAQ:205470
Intrinsic Value
Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. [ Read More ]
The intrinsic value of one Humasis Co Ltd stock under the Base Case scenario is 1 907.94 KRW. Compared to the current market price of 1 768 KRW, Humasis Co Ltd is Undervalued by 7%.
Valuation Backtest
Humasis Co Ltd
Run backtest to discover the historical profit from buying and selling Humasis Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Humasis Co Ltd
Current Assets | 277.8B |
Cash & Short-Term Investments | 243B |
Receivables | 23.9B |
Other Current Assets | 10.9B |
Non-Current Assets | 69.5B |
Long-Term Investments | 11.4B |
PP&E | 57.6B |
Other Non-Current Assets | 507.6m |
Current Liabilities | 59.8B |
Accounts Payable | 456.3m |
Accrued Liabilities | 7.7B |
Other Current Liabilities | 51.6B |
Non-Current Liabilities | 218.1m |
Long-Term Debt | 171.8m |
Other Non-Current Liabilities | 46.3m |
Earnings Waterfall
Humasis Co Ltd
Revenue
|
13.8B
KRW
|
Cost of Revenue
|
-50.8B
KRW
|
Gross Profit
|
-36.9B
KRW
|
Operating Expenses
|
-15.4B
KRW
|
Operating Income
|
-52.4B
KRW
|
Other Expenses
|
-3.1B
KRW
|
Net Income
|
-55.4B
KRW
|
Free Cash Flow Analysis
Humasis Co Ltd
Profitability Score
Profitability Due Diligence
Humasis Co Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Humasis Co Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Humasis Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Humasis Co Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Humasis Co Ltd
Shareholder Return
Price
Humasis Co Ltd
Average Annual Return | 146.13% |
Standard Deviation of Annual Returns | 266.81% |
Max Drawdown | -81% |
Market Capitalization | 224.9B KRW |
Shares Outstanding | 127 212 932 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2014-12-01. The firm is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.
Contact
IPO
Employees
Officers
The intrinsic value of one Humasis Co Ltd stock under the Base Case scenario is 1 907.94 KRW.
Compared to the current market price of 1 768 KRW, Humasis Co Ltd is Undervalued by 7%.